vs

Side-by-side financial comparison of Progyny, Inc. (PGNY) and TripAdvisor, Inc. (TRIP). Click either name above to swap in a different company.

TripAdvisor, Inc. is the larger business by last-quarter revenue ($411.0M vs $318.4M, roughly 1.3× Progyny, Inc.). Progyny, Inc. runs the higher net margin — 3.9% vs -9.2%, a 13.2% gap on every dollar of revenue. On growth, Progyny, Inc. posted the faster year-over-year revenue change (6.7% vs 0.0%). Progyny, Inc. produced more free cash flow last quarter ($48.6M vs $-122.0M). Over the past eight quarters, Progyny, Inc.'s revenue compounded faster (7.0% CAGR vs 2.0%).

Progyny, Inc. is a leading fertility and family building benefits provider operating primarily in the United States. It partners with employers to offer benefits including in vitro fertilization, fertility preservation, adoption assistance, and surrogacy support, serving millions of members across diverse industry segments.

Tripadvisor is an American company that operates online travel agencies, comparison shopping websites, and mobile apps with user-generated content.

PGNY vs TRIP — Head-to-Head

Bigger by revenue
TRIP
TRIP
1.3× larger
TRIP
$411.0M
$318.4M
PGNY
Growing faster (revenue YoY)
PGNY
PGNY
+6.7% gap
PGNY
6.7%
0.0%
TRIP
Higher net margin
PGNY
PGNY
13.2% more per $
PGNY
3.9%
-9.2%
TRIP
More free cash flow
PGNY
PGNY
$170.6M more FCF
PGNY
$48.6M
$-122.0M
TRIP
Faster 2-yr revenue CAGR
PGNY
PGNY
Annualised
PGNY
7.0%
2.0%
TRIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PGNY
PGNY
TRIP
TRIP
Revenue
$318.4M
$411.0M
Net Profit
$12.5M
$-38.0M
Gross Margin
24.1%
91.5%
Operating Margin
4.8%
-8.3%
Net Margin
3.9%
-9.2%
Revenue YoY
6.7%
0.0%
Net Profit YoY
18.5%
-3900.0%
EPS (diluted)
$0.14
$-0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PGNY
PGNY
TRIP
TRIP
Q4 25
$318.4M
$411.0M
Q3 25
$313.3M
$553.0M
Q2 25
$332.9M
$529.0M
Q1 25
$324.0M
$398.0M
Q4 24
$298.4M
$411.0M
Q3 24
$286.6M
$532.0M
Q2 24
$304.1M
$497.0M
Q1 24
$278.1M
$395.0M
Net Profit
PGNY
PGNY
TRIP
TRIP
Q4 25
$12.5M
$-38.0M
Q3 25
$13.9M
$53.0M
Q2 25
$17.1M
$36.0M
Q1 25
$15.1M
$-11.0M
Q4 24
$10.5M
$1.0M
Q3 24
$10.4M
$39.0M
Q2 24
$16.5M
$24.0M
Q1 24
$16.9M
$-59.0M
Gross Margin
PGNY
PGNY
TRIP
TRIP
Q4 25
24.1%
91.5%
Q3 25
23.2%
92.6%
Q2 25
23.7%
92.1%
Q1 25
23.4%
93.2%
Q4 24
21.3%
93.4%
Q3 24
20.7%
92.5%
Q2 24
22.5%
92.8%
Q1 24
22.4%
93.7%
Operating Margin
PGNY
PGNY
TRIP
TRIP
Q4 25
4.8%
-8.3%
Q3 25
6.9%
12.7%
Q2 25
7.3%
11.2%
Q1 25
7.5%
-3.8%
Q4 24
5.3%
0.2%
Q3 24
4.3%
13.2%
Q2 24
6.8%
7.2%
Q1 24
6.7%
-3.8%
Net Margin
PGNY
PGNY
TRIP
TRIP
Q4 25
3.9%
-9.2%
Q3 25
4.4%
9.6%
Q2 25
5.1%
6.8%
Q1 25
4.6%
-2.8%
Q4 24
3.5%
0.2%
Q3 24
3.6%
7.3%
Q2 24
5.4%
4.8%
Q1 24
6.1%
-14.9%
EPS (diluted)
PGNY
PGNY
TRIP
TRIP
Q4 25
$0.14
$-0.32
Q3 25
$0.15
$0.43
Q2 25
$0.19
$0.28
Q1 25
$0.17
$-0.08
Q4 24
$0.12
$0.03
Q3 24
$0.11
$0.27
Q2 24
$0.17
$0.17
Q1 24
$0.17
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PGNY
PGNY
TRIP
TRIP
Cash + ST InvestmentsLiquidity on hand
$112.2M
$1.0B
Total DebtLower is stronger
$819.0M
Stockholders' EquityBook value
$516.0M
$645.0M
Total Assets
$742.4M
$2.6B
Debt / EquityLower = less leverage
1.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PGNY
PGNY
TRIP
TRIP
Q4 25
$112.2M
$1.0B
Q3 25
$134.0M
$1.2B
Q2 25
$132.5M
$1.2B
Q1 25
$109.2M
$1.2B
Q4 24
$162.3M
$1.1B
Q3 24
$91.5M
$1.1B
Q2 24
$95.0M
$1.2B
Q1 24
$115.0M
$1.2B
Total Debt
PGNY
PGNY
TRIP
TRIP
Q4 25
$819.0M
Q3 25
$821.0M
Q2 25
$822.0M
Q1 25
$1.2B
Q4 24
$831.0M
Q3 24
$832.0M
Q2 24
Q1 24
Stockholders' Equity
PGNY
PGNY
TRIP
TRIP
Q4 25
$516.0M
$645.0M
Q3 25
$560.0M
$707.0M
Q2 25
$515.0M
$627.0M
Q1 25
$467.2M
$643.0M
Q4 24
$422.1M
$943.0M
Q3 24
$434.9M
$944.0M
Q2 24
$456.2M
$857.0M
Q1 24
$571.6M
$825.0M
Total Assets
PGNY
PGNY
TRIP
TRIP
Q4 25
$742.4M
$2.6B
Q3 25
$795.2M
$2.8B
Q2 25
$761.0M
$2.9B
Q1 25
$730.3M
$2.8B
Q4 24
$607.1M
$2.6B
Q3 24
$660.0M
$2.7B
Q2 24
$698.6M
$2.8B
Q1 24
$794.3M
$2.7B
Debt / Equity
PGNY
PGNY
TRIP
TRIP
Q4 25
1.27×
Q3 25
1.16×
Q2 25
1.31×
Q1 25
1.81×
Q4 24
0.88×
Q3 24
0.88×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PGNY
PGNY
TRIP
TRIP
Operating Cash FlowLast quarter
$54.2M
$-103.0M
Free Cash FlowOCF − Capex
$48.6M
$-122.0M
FCF MarginFCF / Revenue
15.3%
-29.7%
Capex IntensityCapex / Revenue
1.8%
4.6%
Cash ConversionOCF / Net Profit
4.34×
TTM Free Cash FlowTrailing 4 quarters
$191.8M
$163.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PGNY
PGNY
TRIP
TRIP
Q4 25
$54.2M
$-103.0M
Q3 25
$50.7M
$44.0M
Q2 25
$55.5M
$202.0M
Q1 25
$49.8M
$102.0M
Q4 24
$52.2M
$-3.0M
Q3 24
$44.5M
$-43.0M
Q2 24
$56.7M
$51.0M
Q1 24
$25.7M
$139.0M
Free Cash Flow
PGNY
PGNY
TRIP
TRIP
Q4 25
$48.6M
$-122.0M
Q3 25
$46.0M
$25.0M
Q2 25
$50.2M
$177.0M
Q1 25
$47.0M
$83.0M
Q4 24
$50.3M
$-26.0M
Q3 24
$42.7M
$-63.0M
Q2 24
$55.8M
$36.0M
Q1 24
$24.9M
$123.0M
FCF Margin
PGNY
PGNY
TRIP
TRIP
Q4 25
15.3%
-29.7%
Q3 25
14.7%
4.5%
Q2 25
15.1%
33.5%
Q1 25
14.5%
20.9%
Q4 24
16.8%
-6.3%
Q3 24
14.9%
-11.8%
Q2 24
18.4%
7.2%
Q1 24
8.9%
31.1%
Capex Intensity
PGNY
PGNY
TRIP
TRIP
Q4 25
1.8%
4.6%
Q3 25
1.5%
3.4%
Q2 25
1.6%
4.7%
Q1 25
0.9%
4.8%
Q4 24
0.6%
5.6%
Q3 24
0.6%
3.8%
Q2 24
0.3%
3.0%
Q1 24
0.3%
4.1%
Cash Conversion
PGNY
PGNY
TRIP
TRIP
Q4 25
4.34×
Q3 25
3.65×
0.83×
Q2 25
3.24×
5.61×
Q1 25
3.31×
Q4 24
4.95×
-3.00×
Q3 24
4.27×
-1.10×
Q2 24
3.44×
2.13×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PGNY
PGNY

Fertility Benefit Services$208.6M66%
Pharmacy Benefit Services$109.8M34%

TRIP
TRIP

Third Party$327.0M80%
The Fork$58.0M14%
Other$26.0M6%

Related Comparisons